The global Oxidative Stress Assay Market, valued at $1.31 billion in 2025, is projected to reach $3.25 billion by 2035, growing at a CAGR of 9.53%. Growth is fueled by rising chronic diseases, pharmaceutical innovation, and advances in biomarker diagnostics like ELISA and flow cytometry. North America leads with 38.52% market share, followed by Europe and Asia-Pacific, the latter having the highest growth rate. Key sectors include cancer research and diabetes, with pharmaceutical and biotech companies as primary users. Outsourcing to contract research organizations is also expanding rapidly.
Moderna's stock surged 14% to a 52-week high following an FDA advisory panel's unanimous endorsement of its flu vaccine for adults 50 and older, a key step before the August 2026 approval date. The rally also reflects optimism from Moderna's recent S...
Germany's Merck KGaA has agreed to acquire Bio-Techne for $11.3 billion, causing Bio-Techne shares to surge before the market opened. This acquisition highlights Merck's strategic expansion in the biotech sector. The deal is significant for investors...
The global HPV vaccines market is projected to grow at a compound annual growth rate (CAGR) of approximately 8% from 2026 to 2034, reaching an estimated market size of $18.4 billion by 2034. This growth is driven by the increasing prevalence of HPV-a...
